These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia. Carella AM; Chimirri F; Podestà M; Pitto A; Piaggio G; Dejana A; Lerma E; Pollicardo N; Vassallo F; Soracco M; Benvenuto F; Valbonesi M; Carlier P; Vimercati R; Prencipe E; Gatti AM; Ferrara RA; Incagliato M; Florio G; Frassoni F Bone Marrow Transplant; 1996 Feb; 17(2):201-5. PubMed ID: 8640167 [TBL] [Abstract][Full Text] [Related]
11. GM-CSF can improve the cytogenetic response obtained with interferon-alpha therapy in patients with chronic myelogenous leukemia. Cortes J; Kantarjian H; O'Brien S; Kurzrock R; Keating M; Talpaz M Leukemia; 1998 Jun; 12(6):860-4. PubMed ID: 9639411 [TBL] [Abstract][Full Text] [Related]
12. High-dose hydroxyurea plus G-CSF mobilize BCR-ABL-negative progenitor cells (CFC, LTC-IC) into the blood of newly diagnosed CML patients at any time of hematopoietic regeneration. Petzer AL; Hochenburger E; Haun M; Duba HCh; Grünewald K; Hoflehner E; Sill H; Linkesch W; Gastl G; Gunsilius E J Hematother Stem Cell Res; 2002 Apr; 11(2):293-300. PubMed ID: 11983100 [TBL] [Abstract][Full Text] [Related]
13. Mobilization of peripheral stem cells with intensive chemotherapy (ICE regimen) and G-CSF in chronic myeloid leukemia. Boqué C; Petit J; Sarrá J; Cancelas JA; Muñoz J; Español JI; de la Banda E; Aventin A; Berlanga J; Ferrá C; Amill B; Torrico C; Azqueta C; Llucià M; García J; Grañena A Bone Marrow Transplant; 1996 Nov; 18(5):879-84. PubMed ID: 8932840 [TBL] [Abstract][Full Text] [Related]
14. High response rate using recombinant interferon-alpha in patients with newly diagnosed chronic myeloid leukemia. Mahon FX; Fabères C; Montastruc M; Si-Mour S; Boiron JM; Marit G; Bilhou-Nabera C; Cony-Makhoul P; Pigneux A; Bernard P; Broustet A; Reiffers J Bone Marrow Transplant; 1996 May; 17 Suppl 3():S33-7. PubMed ID: 8769698 [TBL] [Abstract][Full Text] [Related]
15. Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products. Gordon MK; Sher D; Karrison T; Kebriaei P; Chuang K; Zhang Y; McDonnell D; Artz A; Godley L; Odenike O; Rich E; Michaelis L; Thirman MJ; Wickrema A; van Besien K; Larson RA; Stock W Leuk Lymphoma; 2008 Mar; 49(3):531-7. PubMed ID: 18297531 [TBL] [Abstract][Full Text] [Related]
16. Autologous stem cell transplantation in chronic myeloid leukemia: a single center experience. Pigneux A; Faberes C; Boiron JM; Mahon FX; Cony-Makhoul P; Agape P; Lounici A; Bernard P; Bilhou-Nabera C; Bouzgarrou R; Marit G; Reiffers J Bone Marrow Transplant; 1999 Aug; 24(3):265-70. PubMed ID: 10455364 [TBL] [Abstract][Full Text] [Related]
17. Autologous transplantation with Philadelphia-negative progenitor cells for patients with chronic myeloid leukaemia (CML) failing to attain a cytogenetic response to alpha interferon. McBride NC; Cavenagh JD; Newland AC; Lillington DM; Murrell C; Kelsey SM Bone Marrow Transplant; 2000 Dec; 26(11):1165-72. PubMed ID: 11149726 [TBL] [Abstract][Full Text] [Related]